← Leaderboards
Adonis K Hijaz
University Hospitals Of Cleveland
$5,011,831
Attributed
$6,809,272
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2011–24$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,654,389 · 3
AHRQ$3,154,883 · 1
By mechanism
U18$3,154,883 · 1
R01$2,620,389 · 1
K08$594,000 · 1
R21$440,000 · 1
Top collaborators
- Goutham Rao4 shared
- Ozan Akkus2 shared
Most similar at University Hospitals Of Cleveland
Same institution · by research overlap
- Sarah J Koopman Gonzalez$811,047
Others in their field
Top investigators on “Pelvis”
- Walter John Curran · Thomas Jefferson University$26,641,549
- Caroline M. Tanner · Parkinson'S Institute$16,300,213
- Steven R Cummings · University Of California San Francisco$16,300,213
- Margaret Ann Vizzard · University Of Vermont & St Agric College$9,488,545
- Serdar E Bulun · Northwestern University$8,018,409
- Robert C Bast · University Of Texas Md Anderson Can Ctr$7,994,438
Research focus
PelvisVaginaWomanReportingRecoveryAffectSeveritiesProceduresBladderSuccessRepairedPtosisMorbidity - Disease RateAbdomenOperative Surgical ProceduresChildbirthAccountingFailureExpectationClinical Trials DesignExtravasationFatigueAftercareAmerican
Grant awards (14)
Empowering Women and Providers for Improved Care of Urinary Incontinence : EMPOWER Study$931,188
U18 · FY2024 · HS · contact PI
Patient-Centered Outcomes of Sacrocolpopexy versus Uterosacral Ligament Suspension for the Treatment of Uterovaginal Prolapse$631,874
R01 · FY2024 · HD · contact PI
Empowering Women and Providers for Improved Care of Urinary Incontinence : EMPOWER Study$1,040,699
U18 · FY2023 · HS · contact PI
Patient-Centered Outcomes of Sacrocolpopexy versus Uterosacral Ligament Suspension for the Treatment of Uterovaginal Prolapse$644,192
R01 · FY2023 · HD · contact PI
Empowering Women and Providers for Improved Care of Urinary Incontinence: EMPOWER Study$155,970
U18 · FY2023 · HS · contact PI
Empowering Women and Providers for Improved Care of Urinary Incontinence : EMPOWER Study$1,027,026
U18 · FY2022 · HS · contact PI
Patient-Centered Outcomes of Sacrocolpopexy versus Uterosacral Ligament Suspension for the Treatment of Uterovaginal Prolapse$652,355
R01 · FY2022 · HD · contact PI
Patient-Centered Outcomes of Sacrocolpopexy versus Uterosacral Ligament Suspension for the Treatment of Uterovaginal Prolapse$691,968
R01 · FY2021 · HD · contact PI
Immunoregenerative treatment of Stress Urinary Incontinence by Autologous Macrophage Therapy$240,000
R21 · FY2019 · HD
Immunoregenerative treatment of Stress Urinary Incontinence by Autologous Macrophage Therapy$200,000
R21 · FY2018 · HD
Tissue recovery in the pathophysiology of stress urinary incontinence$148,500
K08 · FY2014 · DK · contact PI
Tissue recovery in the pathophysiology of stress urinary incontinence$148,500
K08 · FY2013 · DK · contact PI
Tissue recovery in the pathophysiology of stress urinary incontinence$148,500
K08 · FY2012 · DK · contact PI
Tissue recovery in the pathophysiology of stress urinary incontinence$148,500
K08 · FY2011 · DK · contact PI